Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trigeminovascular effects of propranolol in migraine treatment
2016-000279-26Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in migraine comparing Propranolol arm with Placebo arm (2 arms). Primary endpoints: Dermal blood flow response to capsaicin, Dermal blood flow response to saline iontophoresis and 1 more. Started Mar 2016; status: active.
02
Drugs
propranolol
03
Conditions
migraine
Beyond the preview
Go deeper on 2016-000279-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000279-26.